Christina Baik, MD MPH

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    AstraZeneca
    Topic:
    Consulting
    Date added:
    07/01/2024
    Date updated:
    07/01/2024
    Relationship end date:
    06/06/2024
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Daiichi
    Topic:
    Consulting
    Date added:
    07/01/2024
    Date updated:
    07/01/2024
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    BMS
    Topic:
    Consulting
    Date added:
    07/01/2024
    Date updated:
    07/01/2024
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Pfizer
    Topic:
    Consulting
    Date added:
    07/01/2024
    Date updated:
    07/01/2024
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Boehringer
    Topic:
    Consulting
    Date added:
    07/01/2024
    Date updated:
    07/01/2024
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Genentech
    Topic:
    Consulting
    Date added:
    07/01/2024
    Date updated:
    07/01/2024
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Jansen
    Topic:
    Consulting
    Date added:
    07/01/2024
    Date updated:
    07/01/2024
  • Attribution:
    Other
    Type of financial relationship:
    Other
    Ineligible company:
    Blueprint
    Topic:
    Clinical trial funding
    Date added:
    07/01/2024
    Date updated:
    07/01/2024
  • Attribution:
    Other
    Type of financial relationship:
    Other
    Ineligible company:
    Daiichi
    Topic:
    Clinical trial funding
    Date added:
    07/01/2024
    Date updated:
    07/01/2024
  • Attribution:
    Other
    Type of financial relationship:
    Other
    Ineligible company:
    Nuvalent
    Topic:
    Clinical trial funding
    Date added:
    07/01/2024
    Date updated:
    07/01/2024

Pages

Return to 2025 San Francisco Lung Cancer Conference